SCOPUS 정보 검색 플랫폼

Leukemia Research

Volumn 25, Issue 3, 2001, Pages 227-235

Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As2O3) on myeloma cells

(6) Deaglio, Silvia a Canella, Donatella a Baj, Germano a Arnulfo, Alberto a Waxman, Samuel b Malavasi, Fabio a

a UNIVERSITY OF TURIN (Italy)

b MOUNT SINAI SCHOOL OF MEDICINE (United States)

Author keywords

Adhesion; As2O3; Cytotoxicity; Differentiation; Multiple myeloma

Indexed keywords

ARSENIC TRIOXIDE; CD31 ANTIGEN; CD38 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTINEOPLASTIC AGENTS; ARSENICALS; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH INHIBITORS; HUMANS; IMMUNOPHENOTYPING; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, LYMPHOKINE-ACTIVATED; MEMBRANE GLYCOPROTEINS; MULTIPLE MYELOMA; NAD+ NUCLEOSIDASE; OXIDES; TUMOR CELLS, CULTURED;

EID: 0035132207 PISSN: 01452126 EISSN: None Source Type: Journal
DOI: 10.1016/S0145-2126(00)00105-3 Document Type: Article

Times cited : (58)

References (41)

1
- 0028725481
- Differentiation agents in cancer therapy
- (1994) Cancer Chemother. Biol. Response Modif. , vol.15 , pp. 337-366
- Ferrari, A.C.¹ Waxman, S.²

2
- 0031035671
- Differentiation, differentiation/gene therapy and cancer
- (1997) Pharmacol Ther. , vol.73 , pp. 51-65
- Scott, R.E.¹

3
- 0031726065
- Differentiation therapy of leukemia: achievements, limitations and future prospects
- (1998) Int. J. Hematol. , vol.68 , pp. 107-129
- Hozumi, M.¹

4
- 0033067551
- Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia
- (1999) Nat. Med. , vol.5 , pp. 669-676
- Charrad, R.S.¹ Li, Y.² Delpech, B.³ Balitrand, N.⁴ Clay, D.⁵ Jasmin, C.⁶

5
- 0031311596
- Retinoids, neoplasia and differentiation therapy
- (1997) Cancer Chemother. Biol. Response Modif. , vol.17 , pp. 349-362
- Lippman, S.M.¹ Davies, P.J.²

6
- 0032539134
- Scientists explore use of arsenic in therapy
- (1998) J. Natl. Cancer Inst. , vol.90 , pp. 1866-1867
- Miller, M.¹

7
- 0032955702
- Retinoids: present role and future potential
- (1999) Br. J. Cancer , vol.80 , pp. 1-8
- Evans, T.R.¹ Kaye, S.B.²

8
- 0029875959
- Pathogenesis and management of acute promyelocytic leukemia
- (1996) Annu. Rev. Med. , vol.47 , pp. 555-565
- Warrell R.P., Jr.¹

9
- 0031903610
- Acute respiratory distress syndrome due to all-trans retinoic acid
- (1998) Intensive Care Med. , vol.24 , pp. 642
- Gruson, D.¹ Hilbert, G.² Boiron, J.M.³ Portel, L.⁴ Cony-Makoul, P.⁵ Reiffers, J.⁶

10
- 0006156691
- Deaglio S., Mallone R., Arnulfo A., Baj G., Surico N., Dianzani U., et al. CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. Chem Immunol 2000;99-120.

11
- 0028328853
- Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha
- (1994) Cancer Res. , vol.54 , pp. 1746-1752
- Drach, J.¹ McQueen, T.² Engel, H.³ Andreeff, M.⁴ Robertson, K.A.⁵ Collins, S.J.⁶

12
- 0029909008
- Human CD38, a cell-surface protein with multiple functions
- (1996) FASEB J. , vol.10 , pp. 1408-1417
- Mehta, K.¹ Shahid, U.² Malavasi, F.³

13
- 9044254918
- Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells
- (1996) J. Immunol. , vol.156 , pp. 727-734
- Deaglio, S.¹ Dianzani, U.² Horenstein, A.L.³ Fernandez, J.E.⁴ van Kooten, C.⁵ Bragardo, M.⁶

14
- 0031930758
- Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member
- (1998) J. Immunol. , vol.160 , pp. 395-402
- Deaglio, S.¹ Morra, M.² Mallone, R.³ Ausiello, C.M.⁴ Prager, E.⁵ Garbarino, G.⁶

15
- 0032487923
- Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
- (1998) N. Engl. J. Med. , vol.339 , pp. 1341-1348
- Soignet, S.L.¹ Maslak, P.² Wang, Z.G.³ Jhanwar, S.⁴ Calleja, E.⁵ Dardashti, L.J.⁶

16
- 0030610686
- 3 exerts dose-dependent dual effects on APL cells
- (1997) Blood , vol.89 , pp. 3345-3353
- Chen, G.Q.¹ Shi, X.G.² Tang, W.³ Xiong, S.M.⁴ Zhu, J.⁵ Cai, X.⁶

17
- 0031708772
- The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
- (1998) Leukemia , vol.12 , pp. 1383-1391
- Zhang, W.¹ Ohnishi, K.² Shigeno, K.³ Fujisawa, S.⁴ Naito, K.⁵ Nakamura, S.⁶

18
- 0033105268
- Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients
- (1999) Cancer Res. , vol.59 , pp. 1041-1048
- Rousselot, P.¹ Labaume, S.² Marolleau, J.P.³ Larghero, J.⁴ Noguera, M.H.⁵ Brouet, J.C.⁶

19
- 0033066323
- Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro
- (1999) FEBS Lett. , vol.455 , pp. 59-62
- Akao, Y.¹ Nakagawa, Y.² Akiyama, K.³

20
- 0002661693
- CD38 cluster report
- Kishimoto T., et al. (Eds.), Human leukocyte differentiation antigens, Oxford: Pergamon Press
- (1998)
- Morra, M.¹ Deaglio, S.² Mallone, R.³ Di Rosa, G.⁴ Tibaldi, E.⁵ Zini, G.⁶

21
- 0020324298
- Human myeloma cell line carrying a Philadelphia chromosome
- (1982) Science , vol.216 , pp. 997-999
- Karpas, A.¹ Fischer, P.² Swirsky, D.³

22
- 0021856545
- Phenotypic and functional analysis of B cell lines from patients with multiple myeloma
- (1985) Blood , vol.66 , pp. 444-446
- Goldstein, M.¹ Hoxie, J.² Zembryki, D.³ Matthews, D.⁴ Levinson, A.I.⁵

23
- 0031914417
- Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells
- (1998) J. Immunol. , vol.160 , pp. 1106-1115
- Cesano, A.¹ Visonneau, S.² Deaglio, S.³ Malavasi, F.⁴ Santoli, D.⁵

24
- 0032988150
- The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid
- (1999) Br. J. Cancer , vol.80 , pp. 1494-1500
- Alexander, C.L.¹ Edward, M.² MacKie, R.M.³

25
- 0002829905
- Action of iron, cod-liver oil and arsenic on the globular richness of the blood
- (1878) Am. J. Med. Sci. , vol.75 , pp. 74
- Cutler, E.G.¹ Bradford, E.H.²

26
- 0032487940
- Arsenic-new life for an old potion
- (1998) N. Engl. J. Med. , vol.339 , pp. 1389-1391
- Gallagher, R.E.¹

27
- 0030610687
- 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
- (1997) Blood , vol.89 , pp. 3354-3360
- Shen, Z.X.¹ Chen, G.Q.² Ni, J.H.³ Li, X.S.⁴ Xiong, S.M.⁵ Qiu, Q.Y.⁶

28
- 0033233291
- 3) in the treatment of acute promyelocytic leukemia
- (1999) J. Biol. Regul. Homeost. Agents , vol.13 , pp. 195-200
- Zhang, P.¹

29
- 0010740572
- 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins
- (1996) Blood , vol.88 , pp. 1052-1061
- Chen, G.Q.¹ Zhu, J.² Shi, X.G.³ Ni, J.H.⁴ Zhong, H.J.⁵ Si, G.Y.⁶

30
- 0032170898
- Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner
- (1998) Blood , vol.92 , pp. 1497-1504
- Wang, Z.G.¹ Rivi, R.² Delva, L.³ Konig, A.⁴ Scheinberg, D.A.⁵ Gambacorti-Passerini, C.⁶

31
- 0025777573
- The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype
- (1991) Int. J. Cancer , vol.47 , pp. 746-754
- Rivoltini, L.¹ Cattoretti, G.² Arienti, F.³ Mastroianni, A.⁴ Melani, C.⁵ Colombo, M.P.⁶

32
- 0030588613
- CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis
- (1996) J. Immunol. , vol.157 , pp. 4347-4353
- Nishio, M.¹ Spielman, J.² Lee, R.K.³ Nelson, D.L.⁴ Podack, E.R.⁵

33
- 0028230066
- Human CD38: a glycoprotein in search of a function
- (1994) Immunol. Today , vol.15 , pp. 95-97
- Malavasi, F.¹ Funaro, A.² Roggero, S.³ Horenstein, A.⁴ Calosso, L.⁵ Mehta, K.⁶

34
- 0006156854
- Mehta K., Malavasi F. (Eds.), Recent advances in CD38 and related molecules. Basel: Karger
- (2000)

35
- 0032900044
- Human myeloma cells express the CD38 ligand CD31
- (1999) Br. J. Haematol. , vol.105 , pp. 441-444
- Vallario, A.¹ Chilosi, M.² Adami, F.³ Montagna, L.⁴ Deaglio, S.⁵ Malavasi, F.⁶

36
- 0006153933
- +-converting ectoenzymes
- (1999) Res. Trends , vol.2 , pp. 19-36
- Deaglio, S.¹ Mallone, R.² Baj, G.³ Arnulfo, A.⁴ Ortolan, E.⁵ Calosso, L.⁶

37
- 0028889568
- Lymphocyte adhesion to endothelium
- (1995) Crit. Rev. Immunol. , vol.15 , pp. 167-200
- Dianzani, U.¹ Malavasi, F.²

38
- 0030456712
- Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1beta transcription
- (1996) J. Immunol. , vol.157 , pp. 5097-5103
- Koyama, Y.¹ Tanaka, Y.² Saito, K.³ Abe, M.⁴ Nakatsuka, K.⁵ Morimoto, I.⁶

39
- 0033056023
- A physiologically based pharmacokinetic model of inorganic arsenic
- (1999) Regul. Toxicol. Pharmacol. , vol.29 , pp. 128-141
- Yu, D.¹

40
- 0006205240
- Evaluation of arsenic trioxide in breast cancer therapy
- (1999) VIII International Conference on Differentiation Therapy, Montréal, 3-6, October
- Baj, G.¹ Arnulfo, A.² Deaglio, S.³ Mallone, R.⁴ Surico, N.⁵ Malavasi, F.⁶

41
- 0034212785
- Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis
- (2000) Cancer Res. , vol.60 , pp. 3065-3071
- Park, W.H.¹ Seol, J.G.² Kim, E.S.³ Hyun, J.M.⁴ Jung, C.W.⁵ Lee, C.C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.